Dr. Zeenia Kaul, CEO and CSO at ReHeva Biosciences. ReHeva Biosciences, a clinical-stage biopharmaceutical startup founded in 2016, is discovering and developing naturally occurring, complex botanical agents to treat and manage cancer. Their goal is to help people live longer and healthier with cancer, ultimately transforming cancer treatment into disease management. They recently started their first Phase I Clinical trial of their drug, RH324.
“Using this template has saved my marriage! I am more than thrilled!”